Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,250 public trials 883 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Completed

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

NCT00940316

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
Locations
  • Cancer Care & Hematology Specialists of Chicagoland Arlington Heights, Illinois, United States
  • Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States
  • Hematology/Oncology Associates Chicago, Illinois, United States
  • Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View Trial Details
Completed

Strategies and Opportunities to Stop Colon Cancer in Priority Populations

NCT01742065

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Open Door Health Center Arcata, California, United States
  • Mosaic Medical Bend, Oregon, United States
  • Benton and Linn County Health Centers Corvallis, Oregon, United States
  • Virginia Garcia Memorial Health Center Hillsboro, Oregon, United States
View Trial Details
Completed

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

NCT02083653

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Florida Cancer Specialists-Broadway Fort Myers, Florida, United States
  • Hematology - Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 54 locations
View Trial Details
Completed

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

NCT01640405

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain
View Trial Details

Related conditions